Veritas In Silico (TSE:130A) Marketable Securities : 円0.0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Veritas In Silico's Marketable Securities for the quarter that ended in Dec. 2024 was 円0.0 Mil.

Veritas In Silico Marketable Securities Historical Data

The historical data trend for Veritas In Silico's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Marketable Securities Chart

Veritas In Silico Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Veritas In Silico Quarterly Data
	Dec21	Dec22	Sep23	Dec23	Mar24	Jun24	Dec24
Marketable Securities	Get a 7-Day Free Trial			-	-	-	-	-

Veritas In Silico Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Veritas In Silico (TSE:130A) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Veritas In Silico Marketable Securities Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031

Website

https://www.veritasinsilico.com

Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines